Novo Integrated Sciences, Inc. (NVOS)

Novo Integrated Sciences Financials Overview

Financials in millions USD. Fiscal year is September - August.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Revenue Revenue Growth	13.29	13.29	12.57	11.74	9.31	7.86
Revenue Growth	5.75%	5.75%	7.11%	26.14%	18.38%	-16.57%
Gross Profit Gross Profit Growth	5.74	5.74	4.95	4.8	3.82	3.06
Operating Income Operating Income Growth	-8.31	-8.31	-8.55	-9.59	-4.27	-4.23
Net Income Net Income Growth	-16.17	-16.17	-13.21	-32.85	-4.46	-4.92
Earnings Per Share EPS Growth	-0.90	-0.90	-1.30	-11.28	-1.80	-2.13
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Healthcare Services Healthcare Services Growth	8.3	8.3	8.23	8.4	8.86	7.86
Product Sales Product Sales Growth	4.92	4.92	4.34	3.34	0.45	-
Corporate Corporate Growth	0.08	0.08	0.01	0	-	-
Total Total Growth	13.29	13.29	12.57	11.74	9.31	7.86

Cash & Debt

Chart

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Investments Cash & Investments Growth	0.84	0.84	0.42	2.18	8.29	2.07
Total Debt Total Debt Growth	5.98	5.98	4.47	13.47	13.71	4.39
Net Cash (Debt) Net Cash Growth	-5.14	-5.14	-4.06	-11.3	-5.42	-2.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.28	-0.28	-0.40	-3.88	-2.19	-1.01

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Operating Cash Flow Operating Cash Flow Growth	-5.07	-5.07	-2.24	-5.88	-1.02	-0.44
Capital Expenditures CapEx Growth	-0.01	-0.01	-0.05	-0.19	-0.26	-0.01
Free Cash Flow Free Cash Flow Growth	-5.07	-5.07	-2.29	-6.07	-1.28	-0.45
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Gross Margin	43.20%	43.20%	39.40%	40.89%	41.08%	38.91%
Operating Margin	-62.54%	-62.54%	-68.03%	-81.67%	-45.93%	-53.85%
Pretax Margin	-121.32%	-121.32%	-105.55%	-281.71%	-48.05%	-62.64%
Profit Margin	-121.61%	-121.61%	-105.11%	-279.86%	-47.95%	-62.53%
FCF Margin	-38.17%	-38.17%	-18.23%	-51.75%	-13.76%	-5.77%

Valuation

Chart

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2026	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
PS Ratio	0.00	0.45	1.75	4.40	5.18	11.94

Data Source: S&P Global Market Intelligence Last updated: Dec 18, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 6, 2026

Data Sources Report a data error